Symposium

The Symposium Steering Committee

Adaani Frost, MD
Houston, TX – USA

Nazzareno Galiè, MD
Bologna, Italy

Ardeschir Ghofrani, MD
Giessen, Germany              

Marc Humbert, MD
Paris, France

Anne Margaret Keogh, MD             
Sydney, Australia

Michael McGoon, MD
Rochester, MN – USA

Vallerie V. McLaughlin, MD
Ann Arbor, MI - USA

Nicholas Morrell, MD
Cambridge, UK

Lewis J. Rubin, MD
San Diego, CA – USA

Werner Seeger, MD
Giessen, Germany

Gérald Simonneau, MD
Paris, France

Rogerio Souza, MD
Sao Paulo, Brazil

The Symposium Thirteen Task Forces:

  1. Pathology & Pathobiology
  2. Genetics & Genomics
  3. Pathophysiology of the Rv and of the Pulmonary Circulation
  4. PH Haemodynamic Definitions and Clinical Classifications and Characteristics of Specific PAH Subgroups
  5. Diagnosis of Pulmonary Hypertension 
  6. Risk Stratification and Medical Therapy of Pulmonary Arterial Hypertension
  7. Right Ventricular Assistance and Lung Transplantation
  8. Trials Design & New Therapies for Pulmonary Arterial Hypertension
  9. PH due to Left Heart Diseases
  10. PH due to Chronic Lung Diseases
  11. CTEPH
  12. Pediatric PH
  13. Patients Perspectives

 

The Symposium Secretariat

logoiec

I&C s.r.l.
Via Andrea Costa, 202/6
40134 Bologna (IT)

Stefania Parolari and Giulia Delia

Ph: +39 - (0)51.614.4004
Fax: +39 - (0)51.614.2772

@
For registrations and hotel booking: registrations@wsph2018.com

For abstract submission: abstracts@wsph2018.com

For sponsorship: info@wsph2018.com

The symposium at a glance

TIME TUESDAY   FEB 27 TIME WEDNESDAY FEB 28 TIME THURSDAY MARCH 1
08.30‐09.00  Opening Ceremony        
09.00-10.30 1. Pathology & Pathobiology 09.00-10.30 6. Risk Stratification and Medical Therapy of Pulmonary Arterial Hypertension 09.00-10.30 10. PH due to Chronic Lung Diseases
10.30-11.00 coffee break 10.30-11.00 coffee break 10.30-11.00 coffee break
11.00-12.30 2. Genetics & Genomics 11.00-12.30 7. Right Ventricular Assistance and Lung Transplantation 11.00-12.30 11. CTEPH
12.30-13.00  Best Poster Awards Ceremony 12.30-14.00 Lunch and posters 12.30-14.00 Lunch and posters
13.00-14.00 Lunch and posters 14.00-15.30 8. Trials Design & New Therapies for Pulmonary Arterial Hypertension 14.00-15.30 12. Pediatric PH
14.00-15.30 3. Pathophysiology of the RV and of the Pulmonary Circulation 15.30-16.00 coffee break 15.30-16.00 coffee break
15.30-16.00 coffee break 16.00-17.30 9. PH due to Left Heart Diseases 16.00-17.30 13. Patients' Perspectives
16.00-17.30 4. PH Haemodynamic Definitions and Clinical Classifications and Characteristics of Specific PAH Subgroups        
17.30-19.00 5. Diagnosis of Pulmonary Hypertension